Delivery Order SPE2DB20D2002-SPE2DB24FL14E

Award Date 1/4/24
Potential Completion Date 1/5/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Difluprednate 0.05% eye drops in 5ml vials. The contract award, valued at $1,609.29, has an ultimate completion date of January 17, 2023. This contract is a child order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product, with a Ceiling Value of $9,019.58 and an Ultimate Completion Date of April 19, 2023. The contract does not have a Set-Aside designation, indicating it was awarded through open competition. Amerisourcebergen Drug Corp, the prime...
This is a $1,362.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML, a specialty medication, to support military healthcare programs. The delivery order has a completion date of June 29, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly owned subsidiary of the Amerisourcebergen Corporation. The $5,003.35 contract is for the supply of Difluprednate 0.05% eye drops in 5 milliliter vials. The award is associated with a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Difluprednate 0.05% eye drops in 5 ml vials. The $6,885.32 contract has a completion date of November 20, 2024. There is no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Difluprednate 0.05% eye drops. The $5,375.24 firm-fixed-price contract has a completion date of July 26, 2024. Amerisourcebergen, through its corporate office division, provides a wide range of pharmaceutical and medical supplies to various federal agencies and healthcare programs. This contract is part of Amerisourcebergen's...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The order is for Difluprednate 0.05% eye drops, 5 ml, with a ceiling value of $1,634.02. The contract is a firm fixed price delivery order with no set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Difluprednate 0.05% eye drops, a pharmaceutical product, with a ceiling value of $2,017.39. The contract is a firm fixed-price Delivery Order type with a completion date of February 8, 2023. There is no set-aside designation noted for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of DIFLUPREDNATE 0.05% eye drops. The $1,549.50 contract has a completion date of May 2, 2023 and does not have a set-aside designation, indicating full and open competition. AmerisourceBergen Drug Corporation is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, with an ID of SPE2DB20D2002|SPE2DB23FL34T, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,701.72 delivery order is for the supply of Difluprednate 0.05% eye drop, a prescription medication, to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB24FL14E
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, valued at $1,685.84. The contract is for the supply of Difluprednate 0.05% Eye Drop, a prescription ophthalmic medication, with a completion date of January 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. There is no set-aside designation for this specific delivery order.

Generated 2/27/25, 1:18 PM